OBJECTIVE: Predictors and consequences of childhood anaemia in settings with high HIV prevalence are not well known. The aims of the present study were to identify maternal and child predictors of anaemia among children born to HIV-infected women and to study the association between childhood anaemia and mortality. DESIGN: Prospective cohort study. Maternal characteristics during pregnancy and Hb measurements at 3-month intervals from birth were available for children. Information was also collected on malaria and HIV infection in the children, who were followed up for survival status until 24 months after birth. SETTING: Dar es Salaam, Tanzania. SUBJECTS: The study sample consisted of 829 children born to HIV-positive women. RESULTS: Advanced maternal clinical HIV disease (relative risk (RR) for stage > or =2 v. stage 1: 1.31, 95 % CI 1.14, 1.51) and low CD4 cell counts during pregnancy (RR for <350 cells/mm3 v. > or =350 cells/mm3: 1.58, 95 % CI 1.05, 2.37) were associated with increased risk of anaemia among children. Birth weight <2500 g, preterm birth (<34 weeks), malaria parasitaemia and HIV infection in the children also increased the risk of anaemia. Fe-deficiency anaemia in children was an independent predictor of mortality in the first two years of life (hazard ratio 1.99, 95 % CI 1.06, 3.72). CONCLUSIONS: Comprehensive care including highly active antiretroviral therapy to eligible HIV-infected women during pregnancy could reduce the burden of anaemia in children. Programmes for the prevention of mother-to-child transmission of HIV and antimalarial treatment to children could improve child survival in settings with high HIV prevalence.
OBJECTIVE: Predictors and consequences of childhood anaemia in settings with high HIV prevalence are not well known. The aims of the present study were to identify maternal and child predictors of anaemia among children born to HIV-infectedwomen and to study the association between childhood anaemia and mortality. DESIGN: Prospective cohort study. Maternal characteristics during pregnancy and Hb measurements at 3-month intervals from birth were available for children. Information was also collected on malaria and HIV infection in the children, who were followed up for survival status until 24 months after birth. SETTING: Dar es Salaam, Tanzania. SUBJECTS: The study sample consisted of 829 children born to HIV-positive women. RESULTS: Advanced maternal clinical HIV disease (relative risk (RR) for stage > or =2 v. stage 1: 1.31, 95 % CI 1.14, 1.51) and low CD4 cell counts during pregnancy (RR for <350 cells/mm3 v. > or =350 cells/mm3: 1.58, 95 % CI 1.05, 2.37) were associated with increased risk of anaemia among children. Birth weight <2500 g, preterm birth (<34 weeks), malaria parasitaemia and HIV infection in the children also increased the risk of anaemia. Fe-deficiency anaemia in children was an independent predictor of mortality in the first two years of life (hazard ratio 1.99, 95 % CI 1.06, 3.72). CONCLUSIONS: Comprehensive care including highly active antiretroviral therapy to eligible HIV-infectedwomen during pregnancy could reduce the burden of anaemia in children. Programmes for the prevention of mother-to-child transmission of HIV and antimalarial treatment to children could improve child survival in settings with high HIV prevalence.
Authors: Majid Ezzati; Alan D Lopez; Anthony Rodgers; Stephen Vander Hoorn; Christopher J L Murray Journal: Lancet Date: 2002-11-02 Impact factor: 79.321
Authors: Dana Totin; Christopher Ndugwa; Francis Mmiro; Robert T Perry; J Brooks Jackson; Richard D Semba Journal: J Nutr Date: 2002-03 Impact factor: 4.798
Authors: S Blanche; C Rouzioux; M L Moscato; F Veber; M J Mayaux; C Jacomet; J Tricoire; A Deville; M Vial; G Firtion Journal: N Engl J Med Date: 1989-06-22 Impact factor: 91.245
Authors: Elizabeth M Widen; Margaret E Bentley; Charles S Chasela; Dumbani Kayira; Valerie L Flax; Athena P Kourtis; Sascha R Ellington; Zebrone Kacheche; Gerald Tegha; Denise J Jamieson; Charles M van der Horst; Lindsay H Allen; Setareh Shahab-Ferdows; Linda S Adair Journal: J Acquir Immune Defic Syndr Date: 2015-07-01 Impact factor: 3.731
Authors: Scott Dryden-Peterson; Roger L Shapiro; Michael D Hughes; Kathleen Powis; Anthony Ogwu; Claire Moffat; Sikhulile Moyo; Joseph Makhema; Max Essex; Shahin Lockman Journal: J Acquir Immune Defic Syndr Date: 2011-04-15 Impact factor: 3.731
Authors: Ramadhani A Noor; Ajibola I Abioye; Ellen Hertzmark; Anne M Darling; Said Aboud; Ferdinand M Mugusi; Christopher R Sudfeld; Donna Spiegelman; Wafaie W Fawzi Journal: J Nutr Date: 2020-09-01 Impact factor: 4.798
Authors: Scott Dryden-Peterson; Oluwemimo Jayeoba; Michael D Hughes; Haruna Jibril; Kenneth McIntosh; Taolo A Modise; Aida Asmelash; Kathleen M Powis; Max Essex; Roger L Shapiro; Shahin Lockman Journal: PLoS One Date: 2013-09-23 Impact factor: 3.240